+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Carotid and Renal Artery Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • PDF Icon

    Report

  • 55 Pages
  • December 2022
  • Region: Global
  • GlobalData
  • ID: 5714518
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher's Medical Devices sector report, “Carotid and Renal Artery Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update' provides comprehensive information about the Carotid and Renal Artery Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Carotid artery stents are expandable tubes that are implanted in narrowed carotid arteries to increase the flow of blood.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Carotid and Renal Artery Stents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Carotid and Renal Artery Stents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Carotid and Renal Artery Stents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Carotid and Renal Artery Stents Overview

3 Products under Development
3.1 Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
3.2 Carotid and Renal Artery Stents - Pipeline Products by Segment
3.3 Carotid and Renal Artery Stents - Pipeline Products by Territory
3.4 Carotid and Renal Artery Stents - Pipeline Products by Regulatory Path
3.5 Carotid and Renal Artery Stents - Pipeline Products by Estimated Approval Date
3.6 Carotid and Renal Artery Stents - Ongoing Clinical Trials

4 Carotid and Renal Artery Stents - Pipeline Products under Development by Companies
4.1 Carotid and Renal Artery Stents Companies - Pipeline Products by Stage of Development
4.2 Carotid and Renal Artery Stents - Pipeline Products by Stage of Development

5 Carotid and Renal Artery Stents Companies and Product Overview
5.1 Acotec Scientific Holdings Ltd Company Overview
5.2 Contego Medical LLC Company Overview
5.3 CR Bard Inc Company Overview
5.4 Evasc Medical Systems Corp Company Overview
5.5 InspireMD Inc Company Overview
5.6 MicroPort Scientific Corp Company Overview
5.7 Nesstent Ltd. Company Overview
5.8 Palmaz Scientific Inc (Inactive) Company Overview
5.9 SurModics Inc Company Overview

6 Carotid and Renal Artery Stents- Recent Developments
6.1 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer
6.2 Nov 23, 2022: Medtronic Reports Quarterly Earnings
6.3 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
6.4 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
6.5 Sep 07, 2022: Medtronic to appear at September investor conferences
6.6 Aug 23, 2022: Surmodics to Present at Upcoming Gilmartin Emerging Growth Company Showcase Wednesday, August 31, 2022
6.7 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
6.8 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
6.9 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
6.10 Jul 08, 2022: Cordis Names Bryan Loo President of Asia-pacific Region
6.11 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
6.12 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
6.13 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
6.14 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
6.15 Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022
6.16 Feb 10, 2022: Contego Medical Announces Hiring of Steve MacKinnon, Chief Commercialization Officer
6.17 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer

List of Tables
  • Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
  • Carotid and Renal Artery Stents - Pipeline Products by Segment
  • Carotid and Renal Artery Stents - Pipeline Products by Territory
  • Carotid and Renal Artery Stents - Pipeline Products by Regulatory Path
  • Carotid and Renal Artery Stents - Pipeline Products by Estimated Approval Date
  • Carotid and Renal Artery Stents - Ongoing Clinical Trials
  • Carotid and Renal Artery Stents Companies - Pipeline Products by Stage of Development
  • Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
  • Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Carotid Stent - Product Status
  • Carotid Stent - Product Description
  • Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Neuroguard IEP System - Product Status
  • Neuroguard IEP System - Product Description
  • Contego Medical LLC - Ongoing Clinical Trials Overview
  • Neuroguard IEP System - Protection Against Emboli During Carotid Artery Stenting Using a 3-in-1 Delivery System Comprised of a Post-dilation Balloon, Integrated Embolic Filter and a Novel Carotid Stent II
  • CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
  • VIVEXX Carotid Stent - Product Status
  • VIVEXX Carotid Stent - Product Description
  • Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
  • ROSS - Renal Ostial Stent System - Product Status
  • ROSS - Renal Ostial Stent System - Product Description
  • InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview
  • CGuard Embolic Prevention System - Product Status
  • CGuard Embolic Prevention System - Product Description
  • Next Gen CGuard - 5F - Product Status
  • Next Gen CGuard - 5F - Product Description
  • RGuard Renal - Product Status
  • RGuard Renal - Product Description
  • InspireMD Inc - Ongoing Clinical Trials Overview
  • CGuard Embolic Prevention System - A Multicenter, Single-arm, Pivotal Study to Evaluate the Safety and Efficacy of the CGuard Carotid Stent System When Used to Treat Symptomatic and Asymptomatic Carotid Artery Stenosis in Patients Undergoing Carotid Artery Stenting
  • CGuard Embolic Prevention System - A Pivotal Study of the CGuard Carotid Stent System CARENET-III for Prevention of Stroke in Patients in the United States.
  • CGuard Embolic Prevention System - Acute Stroke of Carotid Artery Bifurcation Origin Treated with Use of the Micronet-covered CGUARD Stent Under Transient Flow Reversal Linked with Thrombus Retrieval: SAFEGUARD-STROKE Study
  • CGuard Embolic Prevention System - Carotid Artery Revascularization Using TransCarotid flow Reversal Cerebral Protection And CGUARD MicroNET-covered Embolic Prevention Stent System to Reduce Strokes in Patients with Symptoms or Signs of Cerebral Ischemia: TOP-GUARD Study
  • CGuard Embolic Prevention System - Long-term Outcomes of MicroNet-covered Stent Routine Use for Stroke Prevention in Symptomatic and Increased-risk Asymptomatic Carotid Stenosis Patients Requiring Revascularization by Neurovascular Team Decision: PARADIGM-EXTEND
  • CGuard Embolic Prevention System - OPTIMAl Endovascular Exclusion of High-risk Carotid Plaque Using the CGuard Stent in Patients with Symptoms or Signs of Carotid Stenosis-related Brain Injury: IVUS Controlled Investigator Initiated Multcentric Multi-specialty Study
  • CGuard Embolic Prevention System - Prospective Observational Study of CGuard MicroNet Covered Stent System Use as a Flow Diverter in the Endovascular Exclusion of Carotid Artery Aneurysms. (CGuard Divert-and-HEAL C-HEAL)
  • CGuard Embolic Prevention System - Prospective Observational Study of Procedures with MicroNet Covered Stent Use to Treat Increased Risk Lesions in Arterial Locations Beyond the Carotid Bifurcation - FLOW-Guard Study
  • MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Taurus Carotid Stent - Product Status
  • Taurus Carotid Stent - Product Description
  • Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • NesStent's Stent - Carotid Bifurcation - Product Status
  • NesStent's Stent - Carotid Bifurcation - Product Description
  • Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Micro-Mesh Covered Carotid Stent - Product Status
  • Micro-Mesh Covered Carotid Stent - Product Description
  • SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Renal Stent System - Product Status
  • Renal Stent System - Product Description
  • Glossary
List of Figures
  • Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
  • Carotid and Renal Artery Stents - Pipeline Products by Segment
  • Carotid and Renal Artery Stents - Pipeline Products by Territory
  • Carotid and Renal Artery Stents - Pipeline Products by Regulatory Path
  • Carotid and Renal Artery Stents - Pipeline Products by Estimated Approval Date
  • Carotid and Renal Artery Stents - Ongoing Clinical Trials

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Acotec Scientific Holdings Ltd
  • Contego Medical LLC
  • CR Bard Inc
  • Evasc Medical Systems Corp
  • InspireMD Inc
  • MicroPort Scientific Corp
  • Nesstent Ltd.
  • Palmaz Scientific Inc (Inactive)
  • SurModics Inc